TKNO
Alpha Teknova, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Strong buy
+73/100
Last price
8.75
▼ 0.25 (2.78%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
9.00
Day high
9.41
Day low
8.61
Volume
376.94K
Market cap
$469.77M
P/E (TTM)
—
52W range
1.91 – 9.48
Trailing performance
Returnvs SPY
1W
-3.63%
-5.6%
1M
+26.45%
+25.3%
3M
+69.90%
+65.4%
6M
+201.72%
+183.5%
YTD
+130.26%
+116.0%
1Y
+55.14%
+38.7%
3Y
+213.62%
+131.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TKNO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.00M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 6, 26 | GUNSTREAM STEPHEN Chief Executive Officer |
BUY | 26.00K | $55.80K | Direct |
| Mar 6, 26 | LOWELL MATTHEW Chief Financial Officer |
BUY | 40.00K | $87.62K | Direct |
| Jun 27, 25 | DEMSKI MARTHA J. Director |
SELL | 8.00K | $40.51K | Direct |
| Jun 17, 25 | DEMSKI MARTHA J. Director |
STOCK | 54.30K | $0 | Direct |
| Jun 17, 25 | ROBERTSON BRETT M Director |
STOCK | 54.30K | $0 | Direct |
| Jun 17, 25 | VOS ALEXANDER Director |
STOCK | 54.30K | $0 | Direct |
| Jun 17, 25 | VOS ALEXANDER Director |
STOCK | 54.30K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DEMSKI MARTHA J. |
Director | 12.00K | Sale |
GUNSTREAM STEPHEN |
Chief Executive Officer | 269.50K | Purchase |
LOWELL MATTHEW |
Chief Financial Officer | 168.38K | Purchase |
ROBERTSON BRETT M |
Director | 107.47K | Stock Award(Grant) |
VOS ALEXANDER |
Director | 102.47K | Stock Award(Grant) |
Fundamentals
Market cap$469.77M
Enterprise value$479.74M
Revenue (TTM)$43.70M
Gross profit$15.12M
EBITDA$-8.97M
Net income$-16.77M
EPS (TTM)$-0.30
Free cash flow$-735.25K
Total cash$17.44M
Total debt$27.41M
Book value / share$1.17
Shares outstanding53.69M
Float10.99M
Short % of float14.37%
Dividend yield0.00%
Beta (5Y)0.86
Valuation & profitability ratios
Trailing P/E—
Forward P/E-46.05
PEG ratio—
Price / sales—
Price / book7.50
EV / revenue10.98
EV / EBITDA-53.47
Gross margin34.60%
Operating margin-23.72%
Profit margin-38.37%
Return on equity-24.19%
Return on assets-9.28%
Debt / equity43.78
Current ratio4.49
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $40.52M | $37.74M | $36.68M | $41.42M | +7.4% |
| Operating revenue | $38.69M | $35.98M | $36.68M | $41.42M | +7.5% |
| Cost of revenue | $27.08M | $30.51M | $26.39M | $23.94M | -11.3% |
| Gross profit | $13.44M | $7.23M | $10.30M | $17.48M | +85.9% |
| Research & development | $2.20M | $2.76M | $5.57M | $7.74M | -20.4% |
| Selling, general & admin | $27.07M | $29.47M | $34.78M | $37.45M | -8.1% |
| Total operating expense | $30.42M | $33.38M | $41.49M | $46.33M | -8.9% |
| Operating income | -$16.98M | -$26.15M | -$31.20M | -$28.86M | +35.1% |
| Net interest income | -$710.00K | -$687.00K | -$833.00K | $213.00K | -3.3% |
| Pre-tax income | -$17.20M | -$26.83M | -$37.08M | -$49.39M | +35.9% |
| Tax provision | $58.00K | -$88.00K | -$298.00K | -$1.92M | +165.9% |
| Net income | -$17.26M | -$26.75M | -$36.78M | -$47.47M | +35.5% |
| Net income to common | -$17.26M | -$26.75M | -$36.78M | -$47.47M | +35.5% |
| Basic EPS | -0.32 | -0.57 | -1.16 | -1.69 | +43.9% |
| Diluted EPS | -0.32 | -0.57 | -1.16 | -1.69 | +43.9% |
| EBIT | -$16.49M | -$26.15M | -$36.24M | -$28.86M | +36.9% |
| EBITDA | -$10.15M | -$19.57M | -$30.59M | -$25.69M | +48.1% |
| Basic shares | 53.48M | 46.75M | 31.82M | 28.08M | +14.4% |
| Diluted shares | 53.48M | 46.75M | 31.82M | 28.08M | +14.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $5.91M | $3.71M | $28.48M | $42.24M | +59.4% |
| Cash & short-term investments | $21.34M | $30.40M | $28.48M | $42.24M | -29.8% |
| Accounts receivable | $4.62M | $4.31M | $3.95M | $4.26M | +7.1% |
| Inventory | $7.05M | $6.80M | $11.59M | $12.25M | +3.7% |
| Total current assets | $34.51M | $42.78M | $45.66M | $61.14M | -19.3% |
| Property, plant & equipment | $55.84M | $61.52M | $66.84M | $71.31M | -9.2% |
| Goodwill & intangibles | $11.94M | $13.09M | $14.24M | $17.56M | -8.8% |
| Total assets | $103.58M | $118.77M | $128.59M | $152.26M | -12.8% |
| Total current liabilities | $7.54M | $11.21M | $8.88M | $10.88M | -32.8% |
| Current debt | — | $4.04M | — | — | — |
| Long-term debt | $13.12M | $9.44M | $13.25M | $21.98M | +39.0% |
| Total debt | $28.27M | $30.17M | $30.46M | $42.31M | -6.3% |
| Total liabilities | $34.81M | $36.38M | $38.55M | $52.38M | -4.3% |
| Retained earnings | -$135.79M | -$118.53M | -$91.79M | -$55.01M | -14.6% |
| Shareholder equity | $68.78M | $82.39M | $90.04M | $99.89M | -16.5% |
| Working capital | $26.97M | $31.57M | $36.78M | $50.27M | -14.5% |
| Net tangible assets | $56.83M | $69.30M | $75.80M | $82.33M | -18.0% |
| Shares issued | 53.56M | 53.41M | 40.79M | 28.18M | +0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$17.26M | -$26.75M | -$36.78M | -$47.47M | +35.5% |
| Depreciation & amortisation | $6.34M | $6.58M | $5.66M | $3.17M | -3.6% |
| Stock-based compensation | $3.43M | $3.67M | $4.14M | $3.71M | -6.5% |
| Change in working capital | -$2.68M | -$873.00K | $2.25M | -$7.33M | -206.9% |
| Operating cash flow | -$8.65M | -$12.39M | -$18.81M | -$27.40M | +30.2% |
| Capital expenditure | -$1.15M | -$1.13M | -$7.93M | -$28.15M | -2.0% |
| Investing cash flow | $10.70M | -$27.27M | -$7.74M | -$28.15M | +139.2% |
| Financing cash flow | $151.00K | $14.89M | $12.80M | $10.27M | -99.0% |
| Free cash flow | -$9.79M | -$13.52M | -$26.75M | -$55.55M | +27.5% |
| End cash position | $5.91M | $3.71M | $28.48M | $42.24M | +59.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $12.19M | $11.08M | $9.98M | $10.45M | $10.29M | +10.0% |
| Operating revenue | $12.19M | $10.54M | $9.55M | $10.01M | $10.29M | +15.6% |
| Cost of revenue | $7.30M | $7.29M | $6.74M | $7.25M | $6.30M | +0.1% |
| Gross profit | $4.88M | $3.78M | $3.24M | $3.21M | $3.98M | +29.1% |
| Research & development | $554.00K | $609.00K | $522.00K | $542.00K | $581.00K | -9.0% |
| Selling, general & admin | $6.93M | $7.19M | $7.04M | $6.39M | $6.50M | -3.5% |
| Total operating expense | $7.78M | $8.08M | $7.85M | $7.22M | $7.37M | -3.8% |
| Operating income | -$2.89M | -$4.30M | -$4.61M | -$4.02M | -$3.39M | +32.8% |
| Net interest income | -$252.00K | -$219.00K | -$211.00K | -$190.00K | -$165.00K | -15.1% |
| Pre-tax income | -$3.14M | -$4.51M | -$4.82M | -$4.21M | -$3.55M | +30.3% |
| Tax provision | $30.00K | $47.00K | -$62.00K | $79.00K | $19.00K | -36.2% |
| Net income | -$3.17M | -$4.55M | -$4.76M | -$4.29M | -$3.57M | +30.4% |
| Net income to common | -$3.17M | -$4.55M | -$4.76M | -$4.29M | -$3.57M | +30.4% |
| Basic EPS | -0.06 | -0.08 | -0.09 | -0.08 | -0.07 | +25.0% |
| Diluted EPS | -0.06 | -0.08 | -0.09 | -0.08 | -0.07 | +25.0% |
| EBIT | -$2.89M | -$4.29M | -$4.61M | -$4.02M | -$3.39M | +32.7% |
| EBITDA | -$1.29M | -$2.71M | -$3.03M | -$2.43M | -$1.80M | +52.3% |
| Basic shares | 53.63M | 53.61M | 53.54M | 53.52M | 53.45M | +0.1% |
| Diluted shares | 53.63M | 53.61M | 53.54M | 53.52M | 53.45M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.00M | $4.31M | $5.91M | $3.20M | $3.28M | +39.4% |
| Cash & short-term investments | $17.44M | $17.78M | $21.34M | $22.12M | $24.00M | -2.0% |
| Accounts receivable | $5.41M | $5.67M | $4.62M | $5.13M | $5.14M | -4.7% |
| Inventory | $6.91M | $6.87M | $7.05M | $6.91M | $7.61M | +0.5% |
| Total current assets | $30.82M | $31.67M | $34.51M | $36.56M | $38.06M | -2.7% |
| Property, plant & equipment | $52.56M | $54.13M | $55.84M | $57.52M | $58.56M | -2.9% |
| Goodwill & intangibles | $11.37M | $11.66M | $11.94M | $12.23M | $12.52M | -2.5% |
| Total assets | $95.88M | $98.66M | $103.58M | $107.63M | $110.49M | -2.8% |
| Total current liabilities | $6.87M | $6.90M | $7.54M | $6.94M | $6.48M | -0.3% |
| Long-term debt | $13.22M | $13.17M | $13.12M | $13.08M | $13.03M | +0.4% |
| Total debt | $27.41M | $27.83M | $28.27M | $28.98M | $28.97M | -1.5% |
| Total liabilities | $33.28M | $33.73M | $34.81M | $34.98M | $34.43M | -1.3% |
| Retained earnings | -$143.51M | -$140.34M | -$135.79M | -$131.03M | -$126.75M | -2.3% |
| Shareholder equity | $62.60M | $64.92M | $68.78M | $72.65M | $76.06M | -3.6% |
| Working capital | $23.95M | $24.78M | $26.97M | $29.63M | $31.58M | -3.3% |
| Net tangible assets | $51.23M | $53.27M | $56.83M | $60.42M | $63.54M | -3.8% |
| Shares issued | 53.68M | 53.61M | 53.56M | 53.52M | 53.51M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$3.17M | -$4.55M | -$4.76M | -$4.29M | -$3.57M | — | +30.4% |
| Depreciation & amortisation | $1.59M | $1.58M | $1.58M | $1.59M | $1.59M | — | +1.1% |
| Stock-based compensation | $622.00K | $695.00K | $777.00K | $850.00K | $950.00K | — | -10.5% |
| Change in working capital | -$19.00K | -$1.49M | $1.55M | -$827.00K | -$1.61M | — | +98.7% |
| Operating cash flow | -$471.00K | -$3.36M | -$462.00K | -$1.98M | -$2.10M | — | +86.0% |
| Capital expenditure | -$125.00K | -$221.00K | -$348.00K | -$387.00K | -$207.00K | — | +43.4% |
| Investing cash flow | $1.95M | $1.84M | $3.21M | $1.64M | $2.03M | — | +5.6% |
| Share buybacks | — | — | — | — | $0 | $0 | — |
| Financing cash flow | $224.00K | -$88.00K | -$37.00K | $268.00K | -$28.00K | — | +354.5% |
| Free cash flow | -$596.00K | -$3.58M | -$810.00K | -$2.37M | -$2.31M | — | +83.4% |
| End cash position | $6.00M | $4.31M | $5.91M | $3.20M | $3.28M | — | +39.4% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.02
Positioning, not flow
Max pain
7.50
-14.3% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
13
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
7.50
36 contracts
Heaviest put OI
7.50
1 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.07 | -0.05 | +32.1% |
| Mar 2026 | -0.09 | -0.08 | +13.0% |
| Dec 2025 | -0.09 | -0.09 | +2.2% |
| Sep 2025 | -0.09 | -0.08 | +14.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.05 | 1 | $11.71M | +12.0% |
| Next quarter | -0.09 | 7 | $11.03M | +10.5% |
| Current year | -0.24 | 1 | $46.00M | +13.5% |
| Next year | -0.19 | 1 | $52.45M | +14.0% |
Analyst targets & ownership
Mean target$9.00
High target$12.00
Low target$7.00
Implied upside2.86%
Analyst count6
ConsensusSTRONG BUY
Strong buy / Buy0 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders9.31%
Held by institutions87.35%
Institutions holding113
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
9.03
-3.13% from price
SMA 20
8.20
+6.65% from price
SMA 50
7.28
+20.12% from price
SMA 100
6.09
+43.63% from price
SMA 200
4.58
+91.05% from price
EMA 12
8.71
+0.44% from price
EMA 26
8.16
+7.18% from price
EMA 50
7.43
+17.72% from price
RSI (14)
63.1
Neutral
MACD (12,26,9)
0.55
Hist -0.01
ATR (14)
0.56
6.43% of price
Realised vol 30D
44.8%
Annualised
Bollinger upper
10.13
20, 2σ
Bollinger lower
6.28
20, 2σ
50 / 200 cross
Golden
7.28 vs 4.58
Trend bias
Above 200
+91.05%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.26
More volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
44.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-65.5%
Peak to trough
Max drawdown 5Y
-95.5%
Peak to trough
ATR 14
0.56
6.43% of price
Beta (reported)
0.86
5Y monthly, from filing
Short interest
Shares short
1.58M
Prior 1.59M
Change vs prior
-0.7%
Shorts covering
% of float
14.37%
Elevated
% of shares out
2.94%
Against total outstanding
Days to cover
8.0
Crowded exit
Float
10.99M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 17, 26 | Jefferies | INITIATED | — | Buy |
| Aug 11, 26 | BTIG | UPGRADE | Neutral | Buy |
| Aug 5, 26 | Roth Capital | INITIATED | — | Buy |
| Jul 10, 24 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| May 14, 24 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| Mar 12, 24 | BTIG | DOWNGRADE | Buy | Neutral |
| Jul 12, 23 | Keybanc | INITIATED | — | Sector Weight |
| Aug 11, 22 | Stephens & Co. | MAINTAINED | — | Overweight |
| Mar 16, 22 | Stephens & Co. | MAINTAINED | — | Overweight |
| Jul 20, 21 | Stephens & Co. | INITIATED | — | Overweight |
| Jul 20, 21 | Cowen & Co. | INITIATED | — | Outperform |
| Jul 20, 21 | BTIG | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-01
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-06
Proxy Statements
DEFA14A · 2026-04-21
Periodic Financial Reports
10-K · 2026-03-02
Corporate Changes & Voting Matters
8-K · 2026-02-26
Headlines
Alpha Teknova, Pluristyx Announce Preparation of PluriFreeze Drug Master File for US FDA Submission
MT Newswires · 5d ago
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
GlobeNewswire · 5d ago
All You Need to Know About Alpha Teknova (TKNO) Rating Upgrade to Buy
Zacks · 6d ago
Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?
Zacks · 15d ago
Jefferies & Co. Initiates Alpha Teknova With Buy Rating, $9 Price Target
MT Newswires · 20d ago
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
GlobeNewswire · 21d ago
Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference
MarketBeat · 48d ago
Alpha Teknova (TKNO) is a Great Momentum Stock: Should You Buy?
Zacks · 49d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.